Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

DNA Methylation Generates Differential Gene Expression in Sister Stem Cells

By BiotechDaily International staff writers
Posted on 14 Oct 2013
Image: A DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons).
Image: A DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons).
DNA methylation was shown to be primarily responsible for differences in gene expression displayed by "sister" stem cells.

Despite having identical DNA, sister embryonic stem cells (ESCs) can display considerable differences in their molecular characteristics. How stem cells regulate expression of their genes is crucial to many fundamental biological processes, such as embryonic development, regeneration, and turnover of blood, skin, and other tissues in the body, but especially to cancer.

In a study published in the September 26, 2013, online edition of the journal Stem Cell Reports investigators at the Institute of Cancer Research (London, United Kingdom) used a novel microdissection technique to examine differences in expression of 48 key genes between sister stem cells.

Their system, which was based on single cell RNA analysis, revealed considerable diversities between sister ESCs at both pluripotent and differentiated states. When the stem cells were grown in the presence inhibitors that induced the cells to revert to their most primitive stem cell state, gene expression between sister cells was significantly more similar.

DNA methyltransferases were downregulated in the inhibited ESCs, and the loss of these enzymes was sufficient to generate nearly identical sister cells. These results suggest that DNA methylation was a major cause of the diversity between sister cells at the pluripotent states. DNA methylation stably alters the expression of genes in cells as they divide and differentiate from embryonic stem cells into specific tissues. The resulting change is normally permanent and unidirectional, preventing a differentiated cell from reverting back to a stem cell or converting into another type of tissue.

Senior author Dr. Tomoyuki Sawado, leader of the stem cells and chromatin team at The Institute of Cancer Research, said, "Embryonic stem cell division is generally believed to be a symmetrical process, but what we found was that sister cells are actually often quite different from one another. We used a new technique to separate paired stem cells combined with assays that measure RNA in individual cells. Our research showed that sister stem cells display considerable differences in which genes are expressed. These differences are advantageous for normal stem cells in their constantly changing environment, and in cancer cells, the same characteristics can enable them to evade treatments. If we can control a process like DNA methylation that creates diversity in cell populations, we could create more efficient treatments for cancer."

Related Links:

The Institute of Cancer Research



Channels

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.